Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1963 1
1973 1
1975 2
1979 1
1980 2
1981 2
1982 1
1983 2
1984 4
1985 4
1986 6
1987 1
1988 1
1989 3
1990 2
1991 1
1992 3
1994 1
1995 2
1997 1
1999 1
2000 1
2004 1
2005 2
2006 1
2007 2
2008 1
2009 2
2010 3
2011 1
2014 3
2015 2
2016 4
2017 3
2018 8
2019 4
2020 6
2021 14
2022 8
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Refractory DLBCL: Challenges and Treatment.
Goldfinger M, Cooper DL. Goldfinger M, et al. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):140-148. doi: 10.1016/j.clml.2021.09.011. Epub 2021 Sep 20. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34666950 Review.
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
Levitz D, Saunthararajah Y, Fedorov K, Shapiro LC, Mantzaris I, Shastri A, Kornblum N, Sica RA, Shah N, Konopleva M, Gritsman K, Braunschweig I, Cooper DL, Pradhan K, Verma A, Feldman EJ, Goldfinger M. Levitz D, et al. Among authors: goldfinger m. Clin Cancer Res. 2023 Aug 1;29(15):2774-2780. doi: 10.1158/1078-0432.CCR-23-0842. Clin Cancer Res. 2023. PMID: 37341641
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
Aminov S, Giricz O, Melnekoff DT, Sica RA, Polishchuk V, Papazoglu C, Yates B, Wang HW, Sahu S, Wang Y, Gordon-Mitchell S, Leshchenko VV, Schinke C, Pradhan K, Aluri S, Sohn M, Barta SK, Agarwal B, Goldfinger M, Mantzaris I, Shastri A, Matsui W, Steidl U, Brody JD, Shah NN, Parekh S, Verma A. Aminov S, et al. Among authors: goldfinger m. J Clin Invest. 2024 Feb 20;134(8):e175199. doi: 10.1172/JCI175199. J Clin Invest. 2024. PMID: 38376944 Free PMC article.
Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis.
Wei JX, Shastri A, Sica RA, Mantzaris I, Kornblum N, Shah U, Janakiram M, Gritsman K, Verma A, Goldfinger M, Cooper D, Shah N. Wei JX, et al. Among authors: goldfinger m. Haematologica. 2023 Oct 26. doi: 10.3324/haematol.2023.283304. Online ahead of print. Haematologica. 2023. PMID: 37881838 Free article.
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.
Bazarbachi AH, Reef D, Narvel H, Patel R, Al Hamed R, Vikash S, Neupane K, Atalla E, Thakkar A, Rahman S, Shah U, Adrianzen-Herrera D, Quinn R, Zareef S, Rabinovich E, De Castro A, Joseph F, Gillick K, Mustafa J, Khatun F, Lombardo A, Townsend-Nugent L, Abreu M, Chambers N, Elkind R, Shi Y, Wang Y, Derman O, Gritsman K, Steidl U, Goldfinger M, Kornblum N, Shastri A, Mantzaris I, Bachier-Rodriguez L, Shah N, Cooper D, Verma A, Ye BH, Janakiram M, Sica RA. Bazarbachi AH, et al. Among authors: goldfinger m. Clin Hematol Int. 2023 Jun;5(2-3):78-91. doi: 10.1007/s44228-023-00032-y. Epub 2023 Mar 15. Clin Hematol Int. 2023. PMID: 36918485 Free PMC article.
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.
Gonzalez-Lugo JD, Kambhampati S, Yacoub A, Donnellan WB, Berdeja J, Bhagat P, Fehn K, Remy C, Jasra S, Kazemi M, Pradhan K, Kim M, Mantzaris I, Sica RA, Shah N, Goldfinger M, Kornblum N, Gritsman K, Braunschweig I, Steidl U, Will B, Shastri A, Verma A. Gonzalez-Lugo JD, et al. Among authors: goldfinger m. Clin Cancer Res. 2023 Jan 4;29(1):60-66. doi: 10.1158/1078-0432.CCR-22-1457. Clin Cancer Res. 2023. PMID: 36255372 Clinical Trial.
Obituary.
Goldfinger MD. Goldfinger MD. J Integr Neurosci. 2015 Sep;14(3):279-80. doi: 10.1142/S0219635215770026. Epub 2015 Aug 6. J Integr Neurosci. 2015. PMID: 26246437 No abstract available.
Efficacy and safety of CAR-T cell therapy in minorities.
Thakkar A, Abreu M, Pradhan K, Sica RA, Shastri A, Kornblum N, Shah N, Mantzaris I, Gritsman K, Feldman E, Elkind R, Green-Lorenzen S, Verma A, Braunschweig I, Goldfinger M. Thakkar A, et al. Among authors: goldfinger m. Bone Marrow Transplant. 2022 Jul;57(7):1187-1190. doi: 10.1038/s41409-022-01670-1. Epub 2022 Apr 28. Bone Marrow Transplant. 2022. PMID: 35484206 No abstract available.
115 results